Special Issue "Commemorative Issue Celebrating the 20th Anniversary of the Alzheimer’s Foundation of America: Understanding and Treating Alzheimer’s Disease"
Deadline for manuscript submissions: 29 February 2024 | Viewed by 18724
Interests: Alzheimer’s disease; neurodegenerative disorder; rheumatoid arthritis
Special Issues, Collections and Topics in MDPI journals
Special Issue in Metabolites: Advances in Cholesterol and Lipid Metabolism II
Special Issue in International Journal of Molecular Sciences: Novel Hypotheses for Alzheimer's Disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by acognitive decline affecting memory, planning, problem-solving, language, and activities of daily living. Hallmarks of the disease are the accumulation of amyloid-β peptide and hyperphosphorylated tau protein in the brain. Unfortunately, immune-based therapies targeting these proteins have been disappointing, and there is no cure. The principal risk factor for AD is age, and as the population grows older, the global prevalence will increase dramatically. AD is, therefore, an urgent public health problem.
In this Special Issue, we encourage the submission of manuscripts on any aspect of AD diagnosis, pathogenesis and treatment. We welcome original studies, reviews, and opinion articles. This Special Issue will focus on hot topics related to AD, bring in experts in the field to discuss current therapeutic approaches, as well as novel treatments under development. The diagnosis, predictive tools and molecular mechanisms of disease pathophysiology are also of great interest. The importance of lifestyle factors such as diet and physical activity is also recognized. This Special Issue in honor of the 20th Anniversary of the Alzheimer’s Foundation of America will provide a state-of-the-art overview of this subject, which will serve as a valued point of reference for geriatricians, neurologists, internal medicine physicians, psychiatrists, neuroscientists, molecular biologists and healthcare workers.
Dr. Allison B. Reiss
Dr. Aaron Pinkhasov
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Alzheimer’s disease